1. A decade of experience with the glutaraldehyde-tanned human umbilical cord vein graft for revascularization of the lower limb 
Herbert Dardik, M.D., Normand Miller, M.D., Alan Dardik, B.S., Ibrahim M. Ibrahim, M.D., Barry Sussman, M.D., Silvia M. Berry, M.Sc., R.V.T., Fred Wolodiger, M.D., Mark Kahn, M.D., Irving Dardik, M.D. 
Journal of Vascular Surgery 
Volume 7, Issue 2, Pages (February 1988)
DOI: / (88)90153-X
Copyright © 1988 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

2. Fig. 1
Cumulative patency rates for popliteal, crural, and distal arteriovenous fistula (dAVF) reconstructions employing UV-G. Curves depict primary cumulative patency rates (1° CPR), secondary cumulative patency rates (2° CPR), cumulative actual palliation (CAP), and palliation index (PI).
Journal of Vascular Surgery 1988 7, DOI: ( / (88)90153-X)
Copyright © 1988 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

3. Fig. 2
Cumulative patency, limb salvage, and patient survival curves for popliteal, tibial, and peroneal reconstructions employing UV-G. Half-life time determinants are depicted for four major graft reconstruction groups.
Journal of Vascular Surgery 1988 7, DOI: ( / (88)90153-X)
Copyright © 1988 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions